Now Approved: U.S. FDA approves product to reduce the incidence of catheter-related bloodstream infections (CRBSIs) under special pathway for patients receiving hemodialysis.

In the News

August 10, 2016

Taurolidine cited as an emerging technology in the treatment of Catheter Related Bloodstream Infections

Read more at Becker’s Hospital Review: Infection Control & Clinical Quality

LOCK-IT-100 Trial named in column on the risk of bloodstream infections for long term care patients undergoing dialysis.

Read more at McKnight’s Long Term Care